Remembering Dr. Craig Leonardi
The International Psoriasis Council (IPC) remembers Dr. Craig Leonardi, founding member and former President, whose research shaped modern psoriasis treatment.
IMAGE GALLERY
Accurately diagnosing and assessing psoriasis in people with darker skin can be challenging, as many dermatology resources do not fully reflect the diversity of clinical presentations. To address these gaps, the International Psoriasis Council (IPC) developed this educational image tool to support diagnostic accuracy and promote equitable psoriasis care across diverse skin tones.
A global IPC survey informed the development of this resource, which focuses on dermatologists caring for patients with diverse skin tones. The survey identified important differences in plaque color, scale, morphology, and post-inflammatory pigmentation that are often underrepresented in existing references. The curated image collection highlights these variations, with particular attention to high-impact and commonly overlooked sites such as the scalp, genitals, nails, palms, and soles, as well as examples of delayed or untreated disease. Images are contributed by IPC members from all global regions and continue to be added as new submissions are received. The collection represents a diverse range of skin tones, psoriasis subtypes, and clinical settings to improve recognition of psoriasis and promote care equity worldwide.
Terms of Use
The images contained in this gallery are provided for educational purposes only and are not intended for clinical diagnosis or treatment. Users may download and use the images solely for educational, non-commercial purposes. Users must provide appropriate credit to the International Psoriasis Council and the contributing physicians, as specified on the image pages. Please read the full Terms of Use before using any images.
IPC is interested in collecting photographs of psoriasis on all of skin, from all regions of the world. You can submit your photos to be added to this educational tool by completing this form.
Psoriasis plaques can vary widely in color depending on the patient’s skin tone and the severity of the condition. While many dermatology resources often describe plaques as silvery white or pink on lighter skin tones, in patients with darker skin, the presentation can appear different. Plaques may appear more gray, purple, or hyper- or hypopigmented. Notably, pink plaques on darker skin may be more muted or less vibrant pink, distinct from how pink plaques typically appear in lighter skin. This subtlety is often underrepresented in traditional teaching tools.
In psoriasis, both hyperpigmentation and hypopigmentation can occur as part of the healing process or because of post-inflammatory changes:
These pigmentation changes are typically temporary but may persist. Survey results indicate that hyper- and hypopigmentation are more common in patients with darker skin.
Psoriasis plaques are commonly associated with induration and scaling across all skin tones. However, survey results indicate that scaling may appear rougher in people with darker skin, with more uneven, textured layers. Thicker scales may also be present, but this is often due to delayed treatment caused by misdiagnosis or access issues.
Psoriasis on high-impact sites, such as the scalp, face, palms, soles, genitals, and nails, can be particularly challenging for people with darker skin. In these areas, psoriasis may result in pronounced hyperpigmentation or hypopigmentation, leading to persistent discoloration after lesions heal. Differences in how psoriasis presents on darker skin can lead to underdiagnosis or misdiagnosis, complicating timely treatment. These factors contribute to the complexity of managing psoriasis on high-impact sites in patients with darker skin.
The presentation of psoriasis can vary across different skin tones. This section highlights key psoriasis phenotypes—erythrodermic, guttate, palmoplantar, and pustular—showing how these variations appear in diverse skin tones.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
The International Psoriasis Council (IPC) remembers Dr. Craig Leonardi, founding member and former President, whose research shaped modern psoriasis treatment.
IPC Councilor José-Manuel Carrascosa Carrillo, MD, PhD, on the BeNeBio trial and whether dose reduction fits an era focused on disease modification.
What happened in psoriasis at the 2026 EADV Congress? IPC shares highlights from its symposium on personalized medicine, as well as psoriasis sessions and late-breaking research from Vienna.
World Psoriasis Day, observed each year on October 29, was launched by the International Federation of Psoriasis Associations (IFPA) in 2004 to give a voice to the more than 125 million people worldwide living with psoriasis and psoriatic arthritis. To mark this year’s observance, IPC joined the Latin American Society of Psoriasis and Dermoimmunology (SOLAPSO) and the Skin Inflammation and Psoriasis International Network (SPIN) to create a video series around the theme “Look Beyond My Skin,” featuring voices from all three organizations. Missed the videos on social media? Watch the full series on the IPC YouTube channel.
Take Two with IPC gives a longer presentation a second life in two minutes. Each video takes an expert talk IPC has already published (a Take Ten recording or a symposium presentation) and condenses the clinical substance. The series launched this month alongside the World Psoriasis Day campaign with four videos on pediatric psoriasis: Psoriasis Look-Alikes and Anti-TNF-α Induced Skin Eruptions with IPC Board Member Amy Paller, MS, MD; Conventional Therapies with IPC Councilor Mona El-Kalioby, MBBCh, MSc, MD; and Phototherapy in Pediatric Psoriasis with Fernando Valenzuela, MD. New Take Two videos will be featured each month, drawn from the Take Ten with IPC library and recordings from IPC symposia, with a link to the full presentation for each.
Select presentations from the Eczema and Psoriasis Research Incubator: Cross-Disciplinary Innovation Forum, hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the 55th Annual European Society for Dermatological Research (ESDR) Meeting, are now available. Topics include disease endotypes, atopic dermatitis-psoriasis overlap, cardiovascular risk in psoriasis, and genetic susceptibility.
In this Take Ten with IPC video, Juul van den Reek and PhD candidate Liana Barenbrug discuss sex differences in psoriasis, why these distinctions matter, what current research tells us, and which areas should be prioritized in future psoriasis research.